Christian Bioethics is a pivotal journal published by Oxford University Press, dedicated to the interdisciplinary exploration of bioethical issues from a Christian perspective. Since its inception in 1995, the journal has served as a crucial platform for scholars, practitioners, and students to engage with complex ethical questions at the intersection of medicine, philosophy, and religious studies. With an evolving scope that reflects contemporary debates in bioethics, the journal has achieved notable rankings, including Q2 in Religious Studies and Q3 in Philosophy in 2023, underscoring its significance in these fields. While not open access, Christian Bioethics continues to bridge gaps between faith and science, encouraging rigorous dialogue on how Christian ethics can inform bioethical decision-making and policy. It is essential reading for those looking to deepen their understanding of ethical issues shaped by religious convictions, making it an invaluable resource for researchers and professionals alike.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS is a premier journal published by Cambridge University Press, focusing on significant issues at the intersection of healthcare, ethics, and policy. With an ISSN of 0963-1801 and an E-ISSN of 1469-2147, this journal serves as a vital platform for discourse among researchers, practitioners, and scholars in the health social sciences. Emphasizing vital ethical considerations in healthcare practices and policies, it ranks in the Q3 tier for Health Policy and Q2 for both Health (Social Science) and Issues, Ethics, and Legal Aspects according to the 2023 journal category quartiles. The journal, spanning its tenure from 1992 to 2024, features rigorous peer-reviewed articles that contribute to the advancement of ethical standards in healthcare. By addressing contemporary ethical dilemmas and promoting scholarly dialogue, CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS remains an essential resource for those committed to understanding the complexities and ethical implications inherent in health systems today.

The International Journal of Chinese & Comparative Philosophy of Medicine, published by GLOBAL SCHOLARLY PUBLICATIONS, is a pivotal scholarly platform dedicated to advancing the discourse around traditional Chinese medicine and comparative philosophies in healthcare. With the ISSN 1386-6354, this journal provides a rich repository of peer-reviewed articles that explore integrative approaches to medicine, addressing both historical context and contemporary applications. Although specific metrics such as impact factor are currently unavailable, it aspires to foster interdisciplinary dialogue among researchers, professionals, and students by encouraging innovative thinking and comparative analysis within the realm of medical philosophy. While currently operating under non-open access guidelines, the journal remains committed to disseminating knowledge that bridges diverse medical practices, making it an invaluable resource for those engaged in the study and application of philosophical medicine.

MEDICINE SCIENCE AND THE LAW is a prestigious journal published by SAGE PUBLICATIONS INC, focused on the intersection of law, health policy, and ethical issues as they pertain to medicine. With a long-standing history dating back to 1960, this journal has become a crucial platform for scholars and professionals alike to share and disseminate research that shapes the evolving legal landscape surrounding health care practices. It holds notable positions in the academic community, ranking in the Q3 category for Health Policy and Issues, Ethics and Legal Aspects, and achieving a distinguished Q1 ranking in Law as of 2023. With rigorous peer-review standards and a commitment to publishing high-quality research, MEDICINE SCIENCE AND THE LAW is invaluable for those exploring the critical legal challenges and ethical dilemmas faced within the healthcare sector. Research contributions are vital for informing policy and practice, ensuring that the journal remains a relevant and essential resource for researchers, practitioners, and students dedicated to the intersection of law and medicine.

Asian Bioethics Review, published by SPRINGER, is a premier journal indexed with ISSN 1793-8759 and E-ISSN 1793-9453, dedicated to advancing discourse in the interdisciplinary field of bioethics across Asia and beyond. Established in 2015, this esteemed publication has rapidly gained recognition, achieving a Q1 ranking in Philosophy and Q2 in key categories such as Health Policy and Issues, Ethics and Legal Aspects in 2023. With its robust Scopus rankings highlighting its significance across diverse domains—including a remarkable 98th percentile ranking in Philosophy—the journal serves as a vital platform for researchers, ethicists, and policymakers to explore pressing ethical issues and contribute to policy development in health and social sciences. Although not open access, the journal ensures a wide reach through institutional subscriptions, making it an essential resource for students and professionals committed to ethical practices in healthcare. Set in the dynamic backdrop of Singapore, "Asian Bioethics Review" continues to shape the conversation around bioethical practices in the Asian context and globally.

South African Journal of Bioethics and Law, published by HEALTH & MEDICAL PUBLISHING GROUP, stands as a vital academic platform for discussions at the intersection of bioethics and legal studies. With an ISSN of 1999-7639, this journal has embraced an Open Access model since 2008, ensuring global accessibility for researchers, practitioners, and students alike. Based in South Africa, the journal operates from PRIVATE BAG X1, PINELANDS, CAPE TOWN 7430, and features diverse articles that span a multitude of pertinent topics across health professions, law, and public health. It proudly holds a Q3 ranking in Health Professions and Law sectors, affirming its status within the scholarly community. Notably, for the year 2023, it has achieved impressive placements in Scopus ranks, reinforcing its commitment to disseminating high-quality research and fostering dialogues that influence policy and practice in these critical domains. Researchers exploring the intricate ethical and legal dimensions of healthcare will find this journal an indispensable resource.

BMC Medical Ethics is a leading open-access journal dedicated to the critical exploration and dissemination of knowledge surrounding ethical issues in healthcare and medicine. Published by BMC, and headquartered in the United Kingdom, this journal has become a cornerstone in the field since its inception in 2000, with a remarkable focus on health policy, nursing ethics, and the complex legal aspects intertwining with healthcare practices. With an impressive Q1 ranking across multiple categories, including Health Policy and Health (Social Science), it ranks among the top journals globally—particularly notable with its Scopus rankings reflecting a strong 85th percentile in Nursing and an 81st percentile in Social Sciences. As an open-access publication, BMC Medical Ethics ensures that research findings are readily accessible, fostering a collaborative environment for researchers, practitioners, and students alike. The journal's commitment to ethical discourse not only advances academic inquiry but also shapes the practices and policies that govern healthcare delivery; thus, making it an invaluable resource for those engaged in the advancement of medical ethics.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

Cuadernos de Bioetica, published by the ASOC ESPANOLA BIOETICA & ETICA MEDICA, is a prominent academic journal dedicated to exploring significant philosophical, ethical, and legal dimensions within the field of bioethics. With an ISSN of 1132-1989 and an E-ISSN of 2386-3773, this journal serves as a vital platform for researchers, professionals, and students in medicine and related disciplines. Since its inception in 2008, it has consistently provided critical analyses and discussions reflecting the evolving landscape of healthcare ethics, contributing notably to the discourse surrounding ethical practices in medicine. Despite its current Q4 ranking in the miscellaneous medicine category, Cuadernos de Bioetica is committed to enhancing its impact and relevance, making it an essential resource for those seeking to navigate the complex ethical challenges in contemporary medical practice. The journal’s reach is underscored by its commitment to fostering open dialogue among diverse stakeholders in the field, encouraging a broad spectrum of contributions to advance knowledge in bioethics.